Literature DB >> 8043330

Temporal influences on the prediction of postinfarction mortality by heart rate variability: a comparison with the left ventricular ejection fraction.

O Odemuyiwa1, J Poloniecki, M Malik, T Farrell, R Xia, A Staunton, P Kulakowski, D Ward, J Camm.   

Abstract

OBJECTIVE: To examine the influence of the duration of follow up on the values of heart rate variability (HRV) and the left ventricular ejection fraction (LVEF) for predicting mortality after infarction.
BACKGROUND: HRV is an index of autonomic balance that identifies patients at a high risk of arrhythmic events. The index is most depressed during the first few weeks after myocardial infarction whereas left ventricular function tends to deteriorate with time. HYPOTHESIS: The value of depressed HRV measured before discharge from hospital for predicting mortality after infarction should decline with time.
METHODS: The HRV and the LVEF were assessed in 433 survivors of a first acute myocardial infarction: HRV < 20 units and LVEF < 40% were taken as cut off points. Kaplan-Meier survival functions for total cardiac mortality and sudden cardiac death were calculated for the whole five year follow up period and for different intervening periods.
RESULTS: During follow up of four weeks to five years there were 46 (10.6%) deaths and 15 (3.5%) patients died suddenly. Within the whole follow up period, HRV < 20 units and LVEF < 40% were both strongly associated with total cardiac mortality (p < 0.0001), but HRV was an independent predictor of total cardiac mortality only during the first six months of follow up. There were no deaths predicted by HRV < 20 units after the first year of follow up whereas LVEF < 40% had a sensitivity of 43% and a positive predictive accuracy of 9% for predicting death during this period. HRV < 20 units was better than LVEF < 40% in predicting sudden deaths during the first year of follow up but was an independent predictor only of those sudden deaths occurring within six months of infarction.
CONCLUSIONS: The duration of follow up affects the prediction of sudden death and total cardiac mortality from HRV. Reduced HRV as measured before discharge from hospital does not seem to retain independent prognostic value after six months of follow up. These findings have potential implications for the serial evaluation of HRV and for the prevention of sudden death after myocardial infarction.

Entities:  

Mesh:

Year:  1994        PMID: 8043330      PMCID: PMC1025445          DOI: 10.1136/hrt.71.6.521

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  24 in total

1.  Activation of left ventricular receptors with nonmedullated vagal afferent fibers during occlusion of a coronary artery in the cat.

Authors:  P N Thorén
Journal:  Am J Cardiol       Date:  1976-06       Impact factor: 2.778

2.  Heart rate variability during the acute phase of myocardial infarction.

Authors:  G C Casolo; P Stroder; C Signorini; F Calzolari; M Zucchini; E Balli; A Sulla; S Lazzerini
Journal:  Circulation       Date:  1992-06       Impact factor: 29.690

Review 3.  Cardiovascular reflexes and autonomic neuropathy.

Authors:  D J Ewing
Journal:  Clin Sci Mol Med       Date:  1978-10

4.  Nervous activity of afferent cardiac sympathetic fibres with atrial and ventricular endings.

Authors:  A Malliani; G Recordati; P J Schwartz
Journal:  J Physiol       Date:  1973-03       Impact factor: 5.182

5.  Beneficial effects of vagal stimulation and bradycardia during experimental acute myocardial ischemia.

Authors:  R W Myers; A S Pearlman; R M Hyman; R A Goldstein; K M Kent; R E Goldstein; S E Epstein
Journal:  Circulation       Date:  1974-05       Impact factor: 29.690

6.  The use of single plane angiocardiograms for the calculation of left ventricular volume in man.

Authors:  H Sandler; H T Dodge
Journal:  Am Heart J       Date:  1968-03       Impact factor: 4.749

7.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

8.  Impaired parasympathetic responses in patients after myocardial infarction.

Authors:  C Ryan; M Hollenberg; D B Harvey; R Gwynn
Journal:  Am J Cardiol       Date:  1976-06       Impact factor: 2.778

9.  Respiratory sinus arrhythmia: noninvasive measure of parasympathetic cardiac control.

Authors:  P G Katona; F Jih
Journal:  J Appl Physiol       Date:  1975-11       Impact factor: 3.531

10.  Sinus arrhythmia in acute myocardial infarction.

Authors:  M M Wolf; G A Varigos; D Hunt; J G Sloman
Journal:  Med J Aust       Date:  1978-07-15       Impact factor: 7.738

View more
  5 in total

Review 1.  The role of the autonomic nervous system in sudden cardiac death.

Authors:  Marmar Vaseghi; Kalyanam Shivkumar
Journal:  Prog Cardiovasc Dis       Date:  2008 May-Jun       Impact factor: 8.194

2.  Prognostic value of left ventricular diastolic function and association with heart rate variability after a first acute myocardial infarction.

Authors:  S H Poulsen; S E Jensen; J E Møller; K Egstrup
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

Review 3.  Heart rate variability: measurement and clinical utility.

Authors:  Robert E Kleiger; Phyllis K Stein; J Thomas Bigger
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-01       Impact factor: 1.468

4.  Heart rate variability and non-linear dynamics in risk stratification.

Authors:  Juha S Perkiömäki
Journal:  Front Physiol       Date:  2011-11-09       Impact factor: 4.566

5.  Does heart rate variability correlate with long-term prognosis in myocardial infarction patients treated by early revascularization?

Authors:  Leonida Compostella; Nenad Lakusic; Caterina Compostella; Li Van Stella Truong; Sabino Iliceto; Fabio Bellotto
Journal:  World J Cardiol       Date:  2017-01-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.